Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(35 sites)
United States
Clinical Site, Bentonville, Arkansas Clinical Site, Little Rock, Arkansas Clinical Site, Anaheim, California Clinical Site, Cerritos, California Clinical Site, Orange, California Clinical Site, Torrance, California Clinical Site, Hialeah, Florida Clinical Site, Miami, Florida Clinical Site, Miami, Florida Clinical Site, Miami, Florida Clinical Site, Miami Lakes, Florida Clinical Site, Miami Lakes, Florida Clinical Site, Tampa, Florida Clinical Site, West Palm Beach, Florida Clinical Site, Atlanta, Georgia Clinical Site, Stockbridge, Georgia Clinical Site, Chicago, Illinois Clinical Site, Chicago, Illinois Clinical Site, Gaithersburg, Maryland Clinical Site, Glen Oaks, New York Clinical Site, Cincinnati, Ohio Clinical Site, Richardson, Texas Serbia
Clinical Site, Kragujevac Clinical Site, Novi Kneževac